KFDA likely to assess clinical effectiveness of new chemically modified medicines

Published: 2008-09-11 07:00:00
Updated: 2008-09-11 07:00:00
The Korea Food and Drug Administration is expected to evaluate the clinical effectiveness of new chemically modified medicines with an improved dosage and administration in the process of granting its market authorization, according to the Ministry of Health, Welfare and Family Affairs.

If th...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.